Patient treatment and outcomes.

Initial induction antifungal regimen, patient mortality through one year, and immune reconstitution inflammatory syndrome (IRIS) by primary disease diagnosis (severe or non-severe) and major underlying condition (HIV, transplant, or HIV-negative and non-transplant).aSevere disease: HIV group had 74 patients, transplant group had 18 patients and 39 patients were in the HIV-negative/non-transplant group; Non-severe disease: HIV group had 12 patients, transplant group had 24 patients and 40 patients were in the HIV-negative/non-transplant group.bHIV-negative, non-transplant.cCochran Mantel-Haenszel Chi-square test for a general association between the three groups was significant for overall mortality among non-severe disease only.